Sickle Cell Drug Development Gains Momentum Across Disease Spectrum

Transplants An Alternative To Genetic Medicines For Some

 
• By Mandy Jackson
  
Vertex and bluebird booths at ASH 2023
Vertex and bluebird presented longer-term data at ASH • Source: Scrip
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D